| Colton Mark Heinrich, OD | |
|
2575 Yorba Linda Blvd, Fullerton, CA 92831-1615 | |
| (714) 449-7401 | |
| Not Available |
| Full Name | Colton Mark Heinrich |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 9 Years |
| Location | 2575 Yorba Linda Blvd, Fullerton, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154701001 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT15222 (California) | Primary |
| 152WC0802X | Optometrist - Corneal And Contact Management | OPT15222 (California) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clarke Eyecare Center Llp | 1052461944 | 4 |
News Archive
A new study examines the use of tissue-engineered scaffolding made of cartilage cells, which have a limited ability to heal naturally, to replace defective cartilage tissue.
Dr. Douglas M. Weissman, MD, FACP is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine. As a gastroenterologist in private practice since 1993, Dr. Weissman specializes in the treatment of all gastrointestinal, biliary and liver disease problems.
Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced positive results from formal studies of its BDM-E eye disease drug, presented over 21 – 22 July at the International Society for Eye Research (ISER) meeting in Berlin, Germany. The ISER convenes leading researchers and clinicians in the area of eye disease.
Mantle cell lymphoma is a very aggressive and difficult to treat cancer originated in blood cells and lymph nodes. To identify the molecular alterations responsible for this tumor, and facilitate the development of new treatments, a team of scientists led by Dr. Xose S. Puente and Dr. Carlos López-Otín, at University of Oviedo, and Dr. Sílvia Beà and Dr. Elias Campo, at IDIBAPS, Hospital Clínic, University of Barcelona, have sequenced the genomes of over 30 of lymphomas.
› Verified 5 days ago
| Provider Name | Clarke Eyecare Center Llp |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1730398306 PECOS PAC ID: 1052461944 Enrollment ID: O20090616000125 |
News Archive
A new study examines the use of tissue-engineered scaffolding made of cartilage cells, which have a limited ability to heal naturally, to replace defective cartilage tissue.
Dr. Douglas M. Weissman, MD, FACP is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine. As a gastroenterologist in private practice since 1993, Dr. Weissman specializes in the treatment of all gastrointestinal, biliary and liver disease problems.
Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced positive results from formal studies of its BDM-E eye disease drug, presented over 21 – 22 July at the International Society for Eye Research (ISER) meeting in Berlin, Germany. The ISER convenes leading researchers and clinicians in the area of eye disease.
Mantle cell lymphoma is a very aggressive and difficult to treat cancer originated in blood cells and lymph nodes. To identify the molecular alterations responsible for this tumor, and facilitate the development of new treatments, a team of scientists led by Dr. Xose S. Puente and Dr. Carlos López-Otín, at University of Oviedo, and Dr. Sílvia Beà and Dr. Elias Campo, at IDIBAPS, Hospital Clínic, University of Barcelona, have sequenced the genomes of over 30 of lymphomas.
› Verified 5 days ago
| Provider Name | Texas State Optical Of Bryan Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275715963 PECOS PAC ID: 5799824363 Enrollment ID: O20091120000514 |
News Archive
A new study examines the use of tissue-engineered scaffolding made of cartilage cells, which have a limited ability to heal naturally, to replace defective cartilage tissue.
Dr. Douglas M. Weissman, MD, FACP is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine. As a gastroenterologist in private practice since 1993, Dr. Weissman specializes in the treatment of all gastrointestinal, biliary and liver disease problems.
Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced positive results from formal studies of its BDM-E eye disease drug, presented over 21 – 22 July at the International Society for Eye Research (ISER) meeting in Berlin, Germany. The ISER convenes leading researchers and clinicians in the area of eye disease.
Mantle cell lymphoma is a very aggressive and difficult to treat cancer originated in blood cells and lymph nodes. To identify the molecular alterations responsible for this tumor, and facilitate the development of new treatments, a team of scientists led by Dr. Xose S. Puente and Dr. Carlos López-Otín, at University of Oviedo, and Dr. Sílvia Beà and Dr. Elias Campo, at IDIBAPS, Hospital Clínic, University of Barcelona, have sequenced the genomes of over 30 of lymphomas.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Colton Mark Heinrich, OD 2575 Yorba Linda Blvd, Fullerton, CA 92831-1615 Ph: (714) 449-7401 | Colton Mark Heinrich, OD 2575 Yorba Linda Blvd, Fullerton, CA 92831-1615 Ph: (714) 449-7401 |
News Archive
A new study examines the use of tissue-engineered scaffolding made of cartilage cells, which have a limited ability to heal naturally, to replace defective cartilage tissue.
Dr. Douglas M. Weissman, MD, FACP is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine. As a gastroenterologist in private practice since 1993, Dr. Weissman specializes in the treatment of all gastrointestinal, biliary and liver disease problems.
Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced positive results from formal studies of its BDM-E eye disease drug, presented over 21 – 22 July at the International Society for Eye Research (ISER) meeting in Berlin, Germany. The ISER convenes leading researchers and clinicians in the area of eye disease.
Mantle cell lymphoma is a very aggressive and difficult to treat cancer originated in blood cells and lymph nodes. To identify the molecular alterations responsible for this tumor, and facilitate the development of new treatments, a team of scientists led by Dr. Xose S. Puente and Dr. Carlos López-Otín, at University of Oviedo, and Dr. Sílvia Beà and Dr. Elias Campo, at IDIBAPS, Hospital Clínic, University of Barcelona, have sequenced the genomes of over 30 of lymphomas.
› Verified 5 days ago
Dr. Lisa M Harrison, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2575 Yorba Linda Blvd, Fullerton, CA 92831 Phone: 714-449-7428 Fax: 714-992-7871 | |
Dr. Regina Seen Won Garriott, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2575 Yorba Linda Blvd, Fullerton, CA 92831 Phone: 714-992-7870 Fax: 714-992-7871 | |
Dr. Carmen Nadine Barnhardt, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2575 Yorba Linda Blvd, Fullerton, CA 92631 Phone: 714-449-7423 Fax: 714-992-7871 | |
California Eye And Ear Specialists Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2240 N Harbor Blvd, 210, Fullerton, CA 92835 Phone: 714-278-1834 Fax: 714-278-1839 | |
Amy A Lytle, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2575 Yorba Linda Blvd, Fullerton, CA 92831 Phone: 714-449-7401 Fax: 717-992-7850 | |
Fullerton Eyes Optometry Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1319 S Harbor Blvd, Fullerton, CA 92832 Phone: 714-525-3330 Fax: 714-525-3334 | |
Dr. Alan Sasai, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2575 Yorba Linda Blvd, Fullerton, CA 92831 Phone: 714-449-7496 Fax: 714-992-7871 |